Fresenius Medical Care Management AG announced On September 26, 2022, Mr. Michael Sen, 53, was elected to the supervisory board of Fresenius Medical Care Management AG, the general partner of Fresenius Medical Care AG & Co. KGaA. He was also elected Chairman of the general partner's supervisory board, effective in both cases October 1, 2022, succeeding Stephan Sturm.

Fresenius SE previously announced that Mr. Sen will become Chief Executive Officer of Fresenius SE on October 1, 2022, to succeed Stephan Sturm. Mr. Sen joined the Management Board of Fresenius Management SE in April 2021 with responsibility for Fresenius Kabi AG, a wholly-owned subsidiary of Fresenius SE specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Mr. Sen will continue to serve as CEO of Fresenius Kabi until a successor is decided for this position.

Before joining Fresenius Kabi, he was a member of the Management Board of Siemens AG, where he was responsible for the healthcare business Siemens Healthineers and for Siemens' energy business. Prior to that, he was Chief Financial Officer of E.ON SE. At the start of his professional career, Mr. Sen completed an apprenticeship at Siemens in Berlin and then studied business administration at the Technical University of Berlin.